**Table S8: Reporting of Primary Results according to CONSORT Guidelines**

|||-------<br>Treatment|Follow-<br>--------------<br>(N=1131)|---Eligible<br>Control(|Follow-<br>Kids--------<br>N=1041)|----------------|<br>Adjusted<br>Difference*<br>(95% CI)||-------<br>Treatment|Follow-<br>---------------<br>(N=442)|--Ineligible<br>Control|Kids-----------<br>(N=382)|-------------|<br>Adjusted<br>Difference*<br>(95% CI)|Adjusted Dif-in-<br>Dif* (95% CI)|
|---|---|---|---|---|---|---|---|---|---|---|---|
||Baseline|Up|Baseline|Up||Baseline|Up|Baseline|Follow-Up|||
|Panel A: Visits|(1)|(2)|(3)|(4)|(5)|(6)|(7)|(8)|(9)|(10)|(11)|
|Total|4.09<br>(5.056)|3.75<br>(4.272)|4.28<br>(4.281)|3.36<br>(3.863)|0.403<br>( 0.013, 0.792)<br>p= 0.043|2.85<br>(3.914)|1.94<br>(2.928)|2.87<br>(4.165)|2.39<br>(3.191)|-0.467<br>(-0.915,-0.018)<br>p=0.041|-0.857<br>(-1.414, -0.300)<br>p=0.003|
|EMP|0.11<br>(1.129)|0.33<br>(1.062)|0.13<br>(0.889)|0.16<br>(0.787)|0.175<br>(0 .080, 0.270)<br>p=0.000|0.02<br>(0.184)|0.02<br>(0.206)|0.00<br>0.000|0.01<br>(0.135)|0.013<br>(-0.011,0.037)<br>p= 0.302|-0.164<br>(-0.258, -0.070)<br>p= 0.001|
|Private Providers|0.96<br>(1.717)|0.72<br>(2.029)|1.12<br>(3.524)|0.66<br>(1.369)|0.062<br>( -0.100, 0.224)<br>p=0.455|0.64<br>(2.247)|0.20<br>(0.603)|0.57<br>(1.386)|0.44<br>(1.292)|-0.248<br>(-0.394, -0.102)<br>p=0.001|-0.304<br>(-0.514,-0.093)<br>p=0.005|
|Panel B: Inv. Hyperbolic||||||||||||
|Expenditures|(1)|(2)|(3)|(4)|(5)|(6)|(7)|(8)|(9)|(10)|(11)|
|Total|4.82<br>(3.169)|4.02<br>(3.317)|4.59<br>(3.238)|4.13<br>(3.288)|-0.077<br>( -0.412, 0.257)<br>p=0.650|3.81<br>(3.236)|2.71<br>(3.121)|3.82<br>(3.261)|3.13<br>(3.334)|-0.437<br>(-0.903,0.029)<br>p=0.066|-0.340<br>(-0.865, 0.184)<br>p=0.203|
|EMP|0.01<br>(0.239)|0.01<br>(0.223)|0.01<br>(0.164)|0.00<br>--|0.01<br>(-0.004, 0.023)<br>p=0.158|0.00<br>--|0.00<br>--|0.00<br>--|0.00<br>--|--<br>--|-0.01<br>(-0.022,0.004)<br>p=0.159|
|Private Providers|2.07<br>(2.884)|1.62<br>(2.673)|1.98<br>(2.869)|1.67<br>(2.723)|-0.021<br>(-0.300, 0.258)<br>p=0.881|1.34<br>(2.469)|0.65<br>(1.849)|1.27<br>(2.458)|1.19<br>(2.472)|-0.547<br>(-0.854,-0.239)<br>p=0.001|-0.508<br>(-0.892,-0.125)<br>p=0.009|

_Notes:_ "Treatment" refers to whether or not the parent respondent was randomly allocated a 6 Month Subsidy for health insurance. Columns 1-4 and 6-9 contain unconditional mean estimates (and sd) for each sample listed for the visits overall, to EMPs, and to private providers (Panel A) or the inverse hyperbolic sine overall, at EMPs, and at private providers (Panel B). Columns 5 and 10 contain the regression-adjusted differences of follow-up measures between the Treatment and Control group, adjusted for round and market fixed effects (i.e., the sampling strategy). Column 11 contains the difference-in-difference estimate between eligible and ineligible children across the treatment and the control groups, adjusted for round and market fixed effects. 95% confidence intervals are displayed between each difference and are calculated based upon standard errors clustered at the family level. The p-value of the t-test on the displayed coefficent is below the 95% confidence interval.

_Source:_ Authors’ analysis based on data described in paper.

8